Delisting risk
CalciMedica (CALC)
Develops CRAC-channel inhibitors for inflammatory and cardiopulmonary disease.
$2.24
Pre-market+0.17 (+7.95%)
At close$2.08(+3.75%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
estimated · in 69 days
EPS estimate
−$1.28
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.34−$0.36−$0.40−$0.39−$0.32−$0.22−$0.45Pending
Estimate−$0.48−$0.43−$0.40−$0.41−$0.55−$0.28−$0.29−$1.28
Surprise+29.2%+16.3%0.0%+4.9%+41.8%+21.4%−57.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————$33.3M———
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.28 | — | — |
| Aug 2026 | −$0.29 | −$0.45 | −57.9% |
| May 2026 | −$0.28 | −$0.22 | +21.4% |
| Mar 2026 | −$0.55 | −$0.32 | +41.8% |
| Nov 2025 | −$0.41 | −$0.39 | +4.9% |
The latest year is open to everyone — the 24 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$1.28 | — | — | — | — | — | — |
| Aug 11, 2026 | −$0.29 | −$0.45 | −57.9% | — | — | — | −0.3% |
| May 12, 2026 | −$0.28 | −$0.22 | +21.4% | — | — | — | +9.5% |
| Mar 3, 2026 | −$0.55 | −$0.32 | +41.8% | $33.3M | — | — | +7.6% |
| Nov 12, 2025 | −$0.41 | −$0.39 | +4.9% | — | — | — | −3.3% |
The latest year is open to everyone — the 24 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Sep 25, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||